- Home
- NVO vs TD Comparison
NVO vs TD Comparison
Compare NVO & TD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVO | TD |
|---|---|---|
| Founded | 1923 | 1855 |
| Country | Denmark | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.7B | 158.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NVO | TD |
|---|---|---|
| Price | $59.78 | $94.32 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 1 |
| Target Price | $54.25 | ★ $120.00 |
| AVG Volume (30 Days) | ★ 19.2M | 2.3M |
| Earning Date | 02-04-2026 | 02-26-2026 |
| Dividend Yield | 2.15% | ★ 3.23% |
| EPS Growth | 10.06 | ★ 144.91 |
| EPS | 3.67 | ★ 8.25 |
| Revenue | ★ $49,580,393,058.00 | $45,149,067,348.00 |
| Revenue This Year | $7.25 | N/A |
| Revenue Next Year | $0.24 | $4.29 |
| P/E Ratio | $15.58 | ★ $11.40 |
| Revenue Growth | 16.64 | ★ 18.83 |
| 52 Week Low | $43.08 | $54.14 |
| 52 Week High | $93.80 | $96.44 |
Technical Indicators
Market Signals| Indicator | NVO | TD |
|---|---|---|
| Relative Strength Index (RSI) | 68.85 | 63.40 |
| Support Level | $56.29 | $92.52 |
| Resistance Level | $60.63 | $94.45 |
| Average True Range (ATR) | 1.27 | 1.17 |
| MACD | 0.45 | -0.45 |
| Stochastic Oscillator | 91.52 | 48.93 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About TD Toronto Dominion Bank (The)
Toronto-Dominion is one of Canada's two largest banks with over CAD 2 trillion in assets. TD Bank operates four business segments: Canadian personal and commercial banking, US retail banking, wealth management and insurance, and wholesale banking. The bank derives more than 50% of its revenue from Canada and has dominant market share in nearly all banking products and services. TD has around 44% of its revenue from its US operations. Its US footprint spans from Maine to Florida, with a strong presence in the Northeast.